logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11793823 B1

PDFFull Text
Date of Patent:
Oct. 24, 2023

Filed:

Mar. 21, 2022

Compounds and pharmaceutical uses thereof

Applicant:

Syneurx International (Taiwan) Corp., New Taipei, TW;

Inventors:

Guochuan Emil Tsai, Pasadena, CA (US);

Yi-Wen Mao, New Taipei, TW;

Lu-Ping Lu, New Taipei, TW;

Wei-Hua Chang, New Taipei, TW;

Han-Yi Hsieh, New Taipei, TW;

Jhe Wei Hu, New Taipei, TW;

Tsai-Miao Shih, New Taipei, TW;

ChanHui Huang, New Taipei, TW;

Assignee:

SyneuRx International (Taiwan) Corp., New Taipei, TW;

Attorney:

McDermott Will & Emery LLP

Primary Examiner:

Jeffrey H Murray

Int. Cl.
CPC ...
C07D 207/34 (2006.01); A61K 31/7048 (2006.01); A23L 33/10 (2016.01); A23L 33/00 (2016.01); A61P 25/18 (2006.01); A61K 31/235 (2006.01); A61K 31/36 (2006.01); A61K 31/40 (2006.01); A61K 31/415 (2006.01); A61K 31/7034 (2006.01); C07C 69/90 (2006.01); C07D 231/14 (2006.01); C07D 317/68 (2006.01); C07H 15/22 (2006.01); C07H 15/26 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7048 (2013.01); A23L 33/10 (2016.08); A23L 33/40 (2016.08); A61K 31/235 (2013.01); A61K 31/36 (2013.01); A61K 31/40 (2013.01); A61K 31/415 (2013.01); A61K 31/7034 (2013.01); A61P 25/18 (2018.01); C07C 69/90 (2013.01); C07D 207/34 (2013.01); C07D 231/14 (2013.01); C07D 317/68 (2013.01); C07H 15/22 (2013.01); C07H 15/26 (2013.01); A23V 2002/00 (2013.01);
Abstract

A compound of Formula (I): or a pharmaceutically acceptable salt thereof, in which Ring X is a 3 to 7 membered monocyclic ring, at least one of R, R, R, and Ris ORor CHORand the other R, R, R, and Reach independently are halogen, OH, OR, CHOR, COH, OC═OR, (C═O)R, R, C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, H, or absent. Also provided herein are therapeutic uses of the compound of Formula (I).

Find Patent Forward Citations

Loading…